SCHEMBL2646474

SCHEMBL2646474

CN(C)C(=O)c1ccc(Oc2cc(Oc3c(F)cccc3F)c3nc(-c4ccccn4)[nH]c3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GCK P35557 8/20 0.45
CBFB Q13951 8/20 0.43
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
DHODH Q02127 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
RUNX1 Q01196 1/20 0.40
TGFBR1 P36897 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2645759 0.92 GCK (0.46) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2646999 0.88 GCK (0.42) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2647266 0.88 GCK (0.42) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2646482 0.86 GCK (0.44) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2647362 0.86 CBFB (0.46) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2644784 0.85 GCK (0.43) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2646267 0.84 GCK (0.42) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2644677 0.83 CBFB (0.49) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2644315 0.83 DHODH (0.46) GCKCBFBALDH1A1TP53CYP3A4
SCHEMBL2644854 0.83 GCK (0.45) GCKCBFBALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1702919-B1 NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE MSD KK (JP) 2012-05-30 EP disclosed
EP-1702919-A1 NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-09-20 EP disclosed